Precision medicine delivered by novel drug delivery systems, ranging from sensors to dose printers, could eventually revolutionize the pharmaceutical industry. Although many of these technologies are years away from commercialization, their ability to provide exact dosing with slow sustained release and more targeted therapy should improve patient compliance and outcomes.
Precision drug-delivery devices with the ability to provide precise doses of drugs to specific sites or tightly-controlled sustained release of a drug are poised to transform many sectors of medicine.
On Nov. 13, 2017, the FDA approved the first drug in the US with a digital ingestion tracking system. Abilify...